Fresh analysis indicates that individuals who discontinue popular GLP-1 drugs like Mounjaro or Wegovy tend to recover reduced body mass much more quickly than those who halt conventional diet and exercise programs.
Findings released in a leading health publication demonstrates that while obese people can lose a large proportion of their body weight while undergoing treatment, the weight comes back at an average rate of 0.8 kg per month upon discontinuation.
"Users purchasing these drugs must be cognizant of the danger of fast weight regain when the treatment concludes," stated expert Dr. Susan Jebb.
This pace of recovery implies a return to original mass within about 18 months.
Comparing Treatments
The study, which examined 37 of studies involving over 9,000 of participants, compared the effects of the injectable medications with conventional dieting.
The team emphasize that individuals who lose weight through lifestyle changes alone typically see a more gradual weight regain—approximately 0.1 kg a month—after stopping.
The Reason for the Quick Rebound
Nutrition scientists believe the mode of action of the drugs accounts for the accelerated weight return.
The injections imitate a natural hormone called glucagon-like peptide-1, which helps regulate hunger.
"Artificially providing GLP-1 concentrations several times higher than normal might result in the body to generate a reduced amount of its own natural hormone, and could diminish responsiveness to its effects," said Dr. Adam Collins, a nutrition specialist.
"Discontinuation of this medication results in appetite is uncontrolled, making overeating a significant risk."
An Ongoing Condition?
Health authorities recommend the jabs for people with obesity-related health risks, accompanied by recommended lifestyle changes.
Many experts contend that, given the high risk of weight regain, the therapy might need to be long-term.
This perspective is reinforced by drug manufacturers, who note that the findings "highlight the chronic nature of excess weight," akin to managing conditions like diabetes.
User Testimonies
Individuals who have come off the jabs explain a powerful resurgence of appetite.
"It felt as if something that goes on and you're instantly extremely hungry," recalled one woman.
This difficulty is worsened if individuals have not developed lasting dietary or behavioural changes during treatment.
Growing Use
Recent estimates indicate that a significant number of people in the UK have used these injections in the last 12 months, with desire continuing to grow.
- Adoption is more common among females compared to males.
- The 40s and 50s age group shows the greatest usage rates.
- A large proportion obtain the drugs through private healthcare rather than the NHS.
Ultimately, experts emphasize that while the jabs are powerful tools for shedding pounds, they are not a permanent cure and lasting health benefits relies on integrated behavioural changes.
